Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Augmenta Bioworks

Augmenta Bioworks?uq=AFYHfsyn
2016 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of novel therapeutics created for infectious diseases with unmet need. The company's drug discovery platform develops antibodies to kill existing and emerging viral and bacterial diseases, enabling patients to create global immunity to diseases.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3475 Edison Way
  • Unit K
  • Menlo Park, CA 94025
  • United States

+1 (805) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Augmenta Bioworks’s full profile, request a free trial.

Augmenta Bioworks Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Augmenta Bioworks Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
StartX Not-For-Profit Venture Capital Minority 000 0000 000000 0
OS Fund Venture Capital Minority 000 0000 000000 0

Augmenta Bioworks Executive Team (2)

Name Title Board
Seat
Contact
Info
Christopher Emig Co-Founder & Chief Executive Officer
Marco Mena Co-Founder & Chief Operating Officer